期刊文献+
共找到48篇文章
< 1 2 3 >
每页显示 20 50 100
Radiotherapy in Non-Functioning Pituitary Macroadenoma: Mansoura Experience 被引量:2
1
作者 Hanan Ahmed Wahba Hend Ahmed EI-Hadaad +1 位作者 Eman Hamza EI-Zahaf Mohammacl ADu-Hegazy 《Clinical oncology and cancer researeh》 CAS CSCD 2011年第4期224-228,共5页
OBJECTIVE The current retrospective study aims to evaluate the management of non-functioning the assessment of experience on pituitary macroadenoma through clinical, biochemical, radiological features, and treatment o... OBJECTIVE The current retrospective study aims to evaluate the management of non-functioning the assessment of experience on pituitary macroadenoma through clinical, biochemical, radiological features, and treatment outcome of patients, and to identify prognostic factors affecting progression-free survival (PFS). METHODS Data of 55 patients macroadenoma presented to the with non-functioning pituitary Clinical Oncology and Nuclear Medicine department between 1998 and 2009 were investigated. RESULTS The most common symptom was visual disturbance (38.2%) followed by headache (27.3%). The presence of male predominance was observed (1.4:1). Ten patients received radio-therapy (RT) only. Extrasellar extension was the more common treatment. The overall response rate was 72.8% with completed response at 16.4%. Memory and intellectual sequelae were the most common late complications of treatment (14%). The ten-year PFS was at 84.6%. PFS was found to be significantly better with higher dose of RT (up to 54 Gy), treatment by both surgery and RT, absence of visual field defect, and tumor localized to sella, whereas it was not significantly affected by age and sex. CONCLUSION The data confirmed that the prevalence of mass effect and hypopituitarism in patients with non-functioning pituitary macroadenoma is elevated. Conventional external RT up to 54 Gy is safe and effective in controlling non-functioning pituitary macro- adenoma with tolerable and acceptable morbidity. 展开更多
关键词 non-functioning pituitary macroadenoma RADIOTHERAPY prognostic factors survival.
下载PDF
Extra-pseudocapsular Transnasal Transsphenoidal Resection of Pituitary Macroadenoma:Technique Note and Evaluation of Endocrine Function 被引量:1
2
作者 Yu XU Xue-yan WAN +6 位作者 Lin-han LI Juan CHEN Jun-wen WANG Kai SHU Michael Buchfelder Rudolf Fahlbusch Ting LEI 《Current Medical Science》 SCIE CAS 2022年第6期1148-1156,共9页
Objective In this study,we investigated the surgical technique and endocrine assessment of pituitary function of patients with macroadenoma treated by extra-pseudocapsular transnasal transsphenoidal surgery(ETTS).Meth... Objective In this study,we investigated the surgical technique and endocrine assessment of pituitary function of patients with macroadenoma treated by extra-pseudocapsular transnasal transsphenoidal surgery(ETTS).Methods Clinical data of 144 patients with pituitary macroadenomas in the same surgical group at the Department of Neurosurgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology were retrospectively analyzed from January 2019 to June 2021.Based on the results of the endocrinological evaluation and MRI examinations before and after surgery,the fluctuation of pituitary function and the extent of resection were analyzed.Multiple Logistic regression analysis was used to determine the predictors affecting postoperative tumor residual.Results Among the 144 patients with pituitary macroadenomas,72(50.0%)were female and 72(50.0%)were male,the median age was 50 years,26(18.1%)had invasiveness grade 0,46(31.9%)had grade I,57(39.6%)had grade II,and 15(10.4%)had grade III according to Lu’s classification method.Based on observation during surgery,37 cases(25.7%)had no pseudocapsule,54 cases(37.5%)had incomplete pseudocapsule,and 53 cases(36.8%)had intact pseudocapsule.In addition,91(63.2%)patients had total resection,39(27.1%)had subtotal resection,and 14(9.7%)had partial resection.As for anterior pituitary function,13 of 19 hypothyroid patients had recovery after surgery,with a remission rate of 68.4%.Eighteen of the 26 decreased cortisol patients got back to normal,with a remission rate of 69.2%.A total of 27 of 51 patients with hypogonadism improved,with a remission rate of 52.9%.Univariate and multivariate analyses indicated that gender,tumor size,and invasiveness were predictors of postoperative residual in patients(P<0.05).Conclusion The results showed that ETTS is an effective treatment modality for restoring the function of pituitary gland of the patients with macroadenomas.Tumor size and invasiveness are predictors of the extent of surgical resection and postoperative residual of macroadenomas. 展开更多
关键词 pseudocapsule pituitary macroadenoma surgical technique transsphenoidal microsurgery
下载PDF
A Rare Case of Non-Functioning Pituitary Macroadenoma (NFMA)
3
作者 O. Rezaee R. Salar +1 位作者 R. Jabari A. Shams Akhtari 《Open Journal of Modern Neurosurgery》 2014年第3期150-153,共4页
NFMAs are benign tumors that do not produce any biologically active hormones and exceed 10 mm (0.39 in) in size. Although NFMAs are benign in origin, mass effects may lead to serious clinical symptoms such as visual i... NFMAs are benign tumors that do not produce any biologically active hormones and exceed 10 mm (0.39 in) in size. Although NFMAs are benign in origin, mass effects may lead to serious clinical symptoms such as visual impairments, chronic headache, and pituitary insufficiency. The authors describe a 51-year-old woman who had a NFMA (35 × 24 × 25 mm). The vision was reduced to 7/10 in the both eyes. A transnasal transsphenoidal surgery was performed and the tumor was successfully resected. Postoperatively, the patient had visual (9/10) and headache improvement. This case highlights a rare presentation of non-functioning pituitary macroadenoma. 展开更多
关键词 Non-Functioning Pituitary macroadenoma (NFMA) TRANSNASAL TRANSSPHENOIDAL Surgery Vision HEADACHE
下载PDF
Visual Disorders Outcome after Endoscopic Endonasal Trans-Sphenoidal Surgery of Pituitary Macroadenomas
4
作者 Wissame El Bakkouri Picard Hervé +8 位作者 Brice Dzidzinyo Abdellaoui Anis Boyeldieu Louise Corré Alain Vignal Catherine Boucenna Malika Ayache Denis 《International Journal of Otolaryngology and Head & Neck Surgery》 2016年第3期134-140,共7页
Objective: Describe the outcome of visual disorders after endonasal transsphenoidal (EET) surgery of pituitary macroadenomas with preoperative chiasmal compression. Patients and Methods: From 2009 to 2013, 225 patient... Objective: Describe the outcome of visual disorders after endonasal transsphenoidal (EET) surgery of pituitary macroadenomas with preoperative chiasmal compression. Patients and Methods: From 2009 to 2013, 225 patients underwent EET surgery for sellar tumor. Among them, 168 suffered from visual disorders induced by chiasmatic compression, of which 88 met the inclusion criteria for this study. Average duration of follow up was 1.8 yrs ± 0.4 yrs. All patients had sellar MRI before surgery and yearly postoperatively, visual acuity (VA) and/or visual field (VF) measurements before, 3 months after surgery and yearly postoperatively. Results: All tumors were macroadenomas with a mean preoperative MRI-estimated volume of 10.0 {plus minus} 9.07 cm<sup>3</sup>. Preoperative VA was impaired with an average of 0.43 ± 0.13 LogMAR (left eye) and 0.36 ± 0.14 LogMAR (right eye) and VF was disturbed in 99% ± 2% of the cases with the most frequent disorder being bitemporal hemianopsia (38 patients). Post-operatively, the mean residual MRI-estimated tumor volume was 3.15 ± 3.71 cm<sup>3</sup>. Mean tumor volume reduction was 62% ± 9% (p < 0.001). Optic chiasmal compression resolved in 72% ± 10% of the cases. Visual function improved in 86% ± 7% of cases (p < 0.001). Conclusion: Endoscopic endonasal management of pituitary gland neoplasms is effective to reduce tumor volume. This technique achieved significant visual improvement in the majority of cases presenting with chiasmal compression syndrome. 展开更多
关键词 PITUITARY macroadenoma Visual Disorder Chiasm Compression Endoscopy TRANSSPHENOIDAL
下载PDF
Pituitary macroadenoma apoplexy as a rare complication of Bruton tyrosine kinase inhibitor in chronic lymphoid leukaemia
5
作者 Aysha Gomaa Robert Skelly 《Chinese Neurosurgical Journal》 CAS CSCD 2023年第4期320-325,共6页
Background Pituitary apoplexy is a neurosurgical emergency and is a known yet rare complication of pituitary macroadenoma.Patients typically present with visual field defects,headache and altered sensorium.There are m... Background Pituitary apoplexy is a neurosurgical emergency and is a known yet rare complication of pituitary macroadenoma.Patients typically present with visual field defects,headache and altered sensorium.There are multiple risk factors for this complication and a thorough drug history is essential to exclude iatrogenic causes of disease.We present an extremely rare case of newly diagnosed pituitary insufficiency unveiled by ibrutinib therapy(a Bruton tyrosine kinase inhibitor).Furthermore,after initial withdrawal of ibrutinib because of the erroneous diagnosis of Syndrome of Inappropriate Antidiuretic Hormone Secretion(SIADH),its re-administration led to the development of classical pituitary apoplexy 4 months after treatment was restarted.Case presentation A male patient in his 60s with a background of chronic lymphocytic leukaemia(CLL)on ibrutinib and venetoclax presents with acute confusion and deranged electrolytes.He is found to be hyponatraemic and is diagnosed with Syndrome of Inappropriate Antidiuretic Hormone Secretion(SIADH)and treated with fluid restriction.He represents again 3 weeks later with hyponatraemia and further investigations reveal pituitary insufficiency and macroadenoma.He was restarted on ibrutinib and venetoclax at the time of discharge.Four months later,he presents with sudden retro-orbital headache associated with vomiting.Clinical findings include cranial nerve III,IV and XI palsy.Humphrey’s visual field examination revealed a left visual field index(VFI)of only 1%while the right was 64%with temporal hemianopia.Both pupils were mid-dilated and poorly reactive to light.MRI pituitary with contrast showed features of pituitary apoplexy and optic nerve compression.He was urgently referred to the neurosurgical team and underwent an emergency trans-sphenoidal hypophysectomy with circumferential excision of the macroadenoma.Post-operative recovery was uneventful with marked improvement in vision bilaterally.The patient was restarted on ibrutinib and venetoclax 2 weeks post-operatively.Approximately 1 year post-treatment,he remains in radiological,clinical and biochemical remission from CLL and all medications have been withdrawn.Conclusions This is a unique and rare case of pituitary macroadenoma apoplexy following the commencement of ibrutinib for CLL.Central nervous system haemorrhage is a rare side effect of ibrutinib due to its platelet dysfunction effects.A thorough assessment is required to assess the risks and benefits of using ibrutinib in patients with pituitary macroadenoma to avoid serious complications. 展开更多
关键词 Pituitary apoplexy Pituitary macroadenoma Chronic lymphocytic leukaemia CHEMOTHERAPY
原文传递
垂体大腺瘤质地术前影像学预测的研究进展
6
作者 李帆 宁刚 《中国CT和MRI杂志》 2023年第8期171-172,共2页
垂体腺瘤是起源于鞍区的垂体前叶原始细胞肿瘤,发病率较高,仅此于胶质瘤和脑膜瘤,根据分类标准不同,可以分为垂体微腺瘤、垂体大腺瘤以及功能性和非功能性垂体腺瘤,而垂体大腺瘤和功能性垂体腺瘤往往会产生临床症状,需要对肿瘤进行手术... 垂体腺瘤是起源于鞍区的垂体前叶原始细胞肿瘤,发病率较高,仅此于胶质瘤和脑膜瘤,根据分类标准不同,可以分为垂体微腺瘤、垂体大腺瘤以及功能性和非功能性垂体腺瘤,而垂体大腺瘤和功能性垂体腺瘤往往会产生临床症状,需要对肿瘤进行手术干预。目前大多数经蝶窦的神经内镜技术可以完整切除肿瘤,但部分质地硬的肿瘤容易残留引起术后复发,因此在术前垂体腺瘤精准评估可以更好的帮助临床。本文旨在总结近年垂体大腺瘤质地术前影像学预测的研究进展。 展开更多
关键词 垂体大腺瘤 质地 胶原蛋白 定量 术前 影像评估
下载PDF
磁共振T2WI对垂体腺瘤质地的评估 被引量:12
7
作者 武春雪 蒙茗 +4 位作者 王政 王朝朝 陈绪珠 李储忠 马军 《磁共振成像》 CAS CSCD 2017年第10期721-725,共5页
目的探讨垂体瘤术前MRI信号特征及其与垂体瘤质地的关系。材料与方法对120例垂体瘤患者依术中所见质地进行分类,比较不同质地组间患者年龄、最大径、T2WI肿瘤/脑白质信号的比值,分析其手术方式和切除程度的差异。结果非实性垂体瘤13例,1... 目的探讨垂体瘤术前MRI信号特征及其与垂体瘤质地的关系。材料与方法对120例垂体瘤患者依术中所见质地进行分类,比较不同质地组间患者年龄、最大径、T2WI肿瘤/脑白质信号的比值,分析其手术方式和切除程度的差异。结果非实性垂体瘤13例,12例质地软,所有非实性垂体瘤均经蝶入路手术,全部为全切或次全切。实性垂体瘤共107例,质软组70例、质韧组30例及混合组7例,质软组肿瘤T2WI信号比显著高于质韧组和混合组(P=0.005、0.000)。质软组切除程度显著高于质韧组(χ~2=14.13,P=0.003)。结论垂体瘤T2WI肿瘤/脑白质信号的比值与其质地和手术方式及切除程度密切相关,可在术前准确判定肿瘤质地,为手术入路的选择提供影像学依据。 展开更多
关键词 磁共振成像 垂体腺瘤 质地 手术方式
下载PDF
经视神经颈内动脉间隙切除视交叉前置型垂体大腺瘤 被引量:8
8
作者 耿军 蔡纪辕 +2 位作者 吴新建 杨泽光 郭予大 《中国神经精神疾病杂志》 CAS CSCD 北大核心 1992年第4期202-205,共4页
本文报告了经视神经颈内动脉间隙显微手术切除视交叉前置型垂体大腺瘤13例,其中全切除1例,次全切除6例,大部切除5例,部分切除1例。术后均获视力改善。本文着重讨论了有关局部显微解剖、手术方法及技术要点。
关键词 垂体大腺瘤 显微外科 手术 视神经
下载PDF
神经导航及内镜辅助下经鼻蝶显微切除无功能性垂体大腺瘤的近期疗效分析 被引量:3
9
作者 吴世强 张卓 +5 位作者 周明辉 吴亢 陈娟 张华楸 舒凯 雷霆 《中国耳鼻咽喉颅底外科杂志》 CAS 2016年第4期284-287,292,共5页
目的探讨神经导航及内镜辅助下经鼻蝶显微切除手术治疗无功能性垂体大腺瘤的近期临床疗效。方法回顾性分析2013年1月-2014年9月诊治的62例无功能性垂体大腺瘤患者的临床资料,按是否使用神经导航及内镜辅助技术分成两组:研究组(32例)... 目的探讨神经导航及内镜辅助下经鼻蝶显微切除手术治疗无功能性垂体大腺瘤的近期临床疗效。方法回顾性分析2013年1月-2014年9月诊治的62例无功能性垂体大腺瘤患者的临床资料,按是否使用神经导航及内镜辅助技术分成两组:研究组(32例)和对照组(30例)。研究组采用神经导航及内镜辅助下经鼻蝶显微切除术,对照组采用常规经鼻蝶显微切除手术。观察比较两组患者术后住院时间、症状缓解、并发症、随访残留及复发情况。结果研究组术后住院时间(6.6±0.7)d明显短于对照组(8.1±0.8)d,术后并发症(尿崩症、脑脊液鼻漏、电解质紊乱、术后瘤腔出血、垂体功能低下等)发生率明显少于对照组,术后症状缓解率高于对照组,术后随访肿瘤残留比例及复发比例明显低于对照组,两组比较差异均具有统计学意义(P〈0.05);按照Knosp分级研究组中Knosp 2级患者的残留比例与对照组的比较,差异具有统计学意义(P〈0.05)。结论在经鼻蝶显微切除手术治疗无功能性垂体大腺瘤中使用神经导航及内镜辅助技术,能减少术后并发症,提高手术全切率,减少术后肿瘤残留,有效控制患者复发,临床近期疗效明显优于常规经鼻蝶显微切除手术。 展开更多
关键词 无功能性垂体腺瘤 神经导航 内镜 疗效
下载PDF
垂体大腺瘤临床及MRI特点在不同性别间的比较 被引量:2
10
作者 陈绪珠 江涛 +1 位作者 王军梅 戴建平 《中国医学影像技术》 CSCD 北大核心 2010年第2期234-237,共4页
目的比较男性和女性垂体大腺瘤的临床及MRI特点。方法230例(男104例,女126例)经病理证实的垂体大腺瘤患者按性别分为两组,分别计算每组的平均年龄、瘤体内出血和海绵窦受累的比率、肿瘤体积,并进行组间比较,同时比较两组病例的病理类型... 目的比较男性和女性垂体大腺瘤的临床及MRI特点。方法230例(男104例,女126例)经病理证实的垂体大腺瘤患者按性别分为两组,分别计算每组的平均年龄、瘤体内出血和海绵窦受累的比率、肿瘤体积,并进行组间比较,同时比较两组病例的病理类型构成。结果男性组年龄、瘤内出血率、海绵窦受累率及肿瘤体积分别为(44.8±13.2)岁、21.15%(22/104)、50.00%(52/104)及6100.48mm3;女性组分别为(44.8±11.9)岁、28.57%(36/126)、48.41%(61/126)及5037.05mm3。两组病例的年龄、瘤内出血率、海绵窦受累率、肿瘤体积及病理类型构成无统计学差异(P=0.972,P=0.197,P=0.811,P=0.189,P=0.093)。结论垂体大腺瘤的临床及MRI特点无性别差异。 展开更多
关键词 垂体大腺瘤 性别 出血 海绵窦 磁共振成像
下载PDF
垂体大腺瘤经蝶显微手术84例 被引量:2
11
作者 蔡瑜 赵卫国 +2 位作者 沈建康 卞留贯 成侃 《中国微创外科杂志》 CSCD 2005年第8期664-665,共2页
目的总结经蝶入路治疗垂体大腺瘤的手术经验. 方法 1999年1月~2003年12月采用经蝶窦入路显微手术治疗垂体大腺瘤84例,其中经右侧鼻腔-鼻中隔-蝶窦入路74例,经唇下-鼻中隔-蝶窦入路10例. 结果手术无死亡.术后MRI复查显示,近全切除(>9... 目的总结经蝶入路治疗垂体大腺瘤的手术经验. 方法 1999年1月~2003年12月采用经蝶窦入路显微手术治疗垂体大腺瘤84例,其中经右侧鼻腔-鼻中隔-蝶窦入路74例,经唇下-鼻中隔-蝶窦入路10例. 结果手术无死亡.术后MRI复查显示,近全切除(>95%)56例(66.7%),次全切除(>85%)18例(21.4%),部分切除(<50%)10例(11.9%).4例部分切除,术后1周再次行经额或经翼点入路手术切除肿瘤.65例随访6~48个月,平均24个月,除3例复发接受放射治疗外,余62例均恢复良好. 结论经蝶显微手术治疗垂体大腺瘤是一种安全、有效的手术技术,术后放疗可以控制肿瘤复发. 展开更多
关键词 垂体大腺瘤 经蝶入路 显微外科手术
下载PDF
垂体瘤转化基因在垂体大腺瘤中的表达及其与肿瘤侵袭性的关系 被引量:2
12
作者 胡静芳 苏青 蔡瑜 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第2期193-195,共3页
目的研究垂体瘤转化基因(PTTG)在垂体大腺瘤中的表达,探讨其与肿瘤侵袭性的关系。方法收集手术和病理证实的垂体大腺瘤40例,其中无功能腺瘤22例,生长激素腺瘤8例,泌乳素腺瘤10例。用免疫组化技术检测垂体大腺瘤中PTTG表达。结合影像资料... 目的研究垂体瘤转化基因(PTTG)在垂体大腺瘤中的表达,探讨其与肿瘤侵袭性的关系。方法收集手术和病理证实的垂体大腺瘤40例,其中无功能腺瘤22例,生长激素腺瘤8例,泌乳素腺瘤10例。用免疫组化技术检测垂体大腺瘤中PTTG表达。结合影像资料,分析PTTG的表达与大腺瘤侵袭性生物学行为的关系。结果40例垂体大腺瘤中均发现PTTG的表达升高,PTTG在侵袭性垂体大腺瘤中的表达显著高于非侵袭性垂体大腺瘤(P<0.01)。结论PTTG的表达与垂体大腺瘤侵袭性的生物学行为有关,其表达程度可用作垂体大腺瘤预后的评估指标,为大腺瘤术后复发以及相应的辅助治疗提供判断依据。 展开更多
关键词 垂体大腺瘤 垂体瘤转化基因 侵袭性 肿瘤侵袭性 基因表达
下载PDF
无功能垂体大腺瘤经蝶窦入路手术后核磁共振随访 被引量:2
13
作者 林富禄 岳志健 +3 位作者 周晓平 魏梁锋 卢旺盛 赵文元 《中国微创外科杂志》 CSCD 2004年第4期326-327,共2页
目的 探讨无功能垂体大腺瘤经蝶窦入路手术后MRI随访的最佳时间。 方法 回顾性分析 5 0例术前、术后 1周内 (早期 )、术后 3个月 (中期 )、术后 1年 (后期 )的MRI资料。观察术后不同时期MRIT1增强前后鞍内容物的变化及判断肿瘤切除... 目的 探讨无功能垂体大腺瘤经蝶窦入路手术后MRI随访的最佳时间。 方法 回顾性分析 5 0例术前、术后 1周内 (早期 )、术后 3个月 (中期 )、术后 1年 (后期 )的MRI资料。观察术后不同时期MRIT1增强前后鞍内容物的变化及判断肿瘤切除的程度。 结果 术后早期MRI显示鞍区内容物高度减小 8%~ 32 % ,肿瘤消失 2 2例 ,怀疑残余肿瘤 2 8例。术后 3个月MRI显示鞍区内容物体积减少 11%~ 85 % ,MRI冠状位上鞍区内容物体积减少 5 0 %以上 11例 ,减少 30 %~ 5 0 % 9例 ,<30 % 8例 ;术后早期怀疑残余肿瘤 2 8例中 ,2 3例确定鞍区存在残余肿瘤。术后 1年MRI显示鞍区内容物无变化 4 6例 ,继续减少 4例。 展开更多
关键词 无功能垂体大腺瘤 经蝶窦手术 核磁共振成像
下载PDF
不同激素分泌类型垂体巨腺瘤的磁共振成像特点 被引量:2
14
作者 李又成 余方芳 +2 位作者 李建策 黎金林 温新东 《放射学实践》 2007年第1期17-20,共4页
目的探讨不同激素分泌类型垂体巨腺瘤的磁共振成像影像特点。方法回顾性分析64例不同激素分泌类型垂体巨腺瘤在MRI上的信号强度、最大径、其向蝶鞍上下延伸生长的高度,及其有无海绵窦侵犯;同时22例无分泌功能垂体巨腺瘤作为对照组纳入... 目的探讨不同激素分泌类型垂体巨腺瘤的磁共振成像影像特点。方法回顾性分析64例不同激素分泌类型垂体巨腺瘤在MRI上的信号强度、最大径、其向蝶鞍上下延伸生长的高度,及其有无海绵窦侵犯;同时22例无分泌功能垂体巨腺瘤作为对照组纳入。结果64例不同激素分泌类型垂体巨腺瘤患者中,生长激素(GH)细胞腺瘤16例,泌乳素(PRL)细胞腺瘤36例,促肾上腺皮质激素(ACTH)细胞腺瘤5例,多种激素细胞腺瘤7例。T1WI等信号在GH及多种激素细胞腺瘤中最常见;T2WI等、低信号在GH、ACTH及多种激素细胞腺瘤中常见,而T2WI高信号在PRL及无分泌功能细胞腺瘤中常见;GH细胞腺瘤鞍上生长高度明显低于其他几种腺瘤,倾向于向鞍下生长;各类型腺瘤的海绵窦侵犯无明显差异。结论几种不同激素分泌类型垂体腺瘤中,GH、多种激素细胞腺瘤的MRI信号强度,以及GH细胞腺瘤的生长延伸方向具有一定的特征。 展开更多
关键词 激素 垂体 腺瘤 磁共振成像
下载PDF
无功能垂体大腺瘤经蝶窦入路手术后核磁共振随访 被引量:1
15
作者 林富禄 岳志健 +3 位作者 周晓平 魏梁锋 卢旺盛 赵文元 《临床神经外科杂志》 CAS 2004年第2期58-60,共3页
目的探讨无功能垂体大腺瘤经蝶窦入路手术后MRI随访的最佳时间。方法回顾性分析50例,分别在术前、术后1周内(早期)、术后3月(中期)、术后1年(后期)的MRI资料。观察术后不同时期MRIT1增强前后鞍内容物的变化及判断肿瘤切除的程度。结果... 目的探讨无功能垂体大腺瘤经蝶窦入路手术后MRI随访的最佳时间。方法回顾性分析50例,分别在术前、术后1周内(早期)、术后3月(中期)、术后1年(后期)的MRI资料。观察术后不同时期MRIT1增强前后鞍内容物的变化及判断肿瘤切除的程度。结果术后早期MRI检查显示多数患者鞍区内容物明显减少,其中28例无法判别残余肿瘤,术后3月后鞍区内容物体积减少,MRI冠状位上鞍区内容物体积减少50%以上的11例,减少30-50%的9例,小于30%的8例。有23例于术后3个月后MRI检查确诊鞍区有残余肿瘤。结论无功能垂体大腺瘤经蝶窦入路术后中期复查MRI容易判断肿瘤残余或复发。 展开更多
关键词 无功能垂体大腺瘤 经蝶窦手术 核磁共振
下载PDF
内镜经鼻蝶入路手术治疗大型垂体腺瘤 被引量:18
16
作者 裴傲 张亚卓 +3 位作者 宗绪毅 王新生 赵澎 宋明 《中国神经肿瘤杂志》 2009年第1期22-24,共3页
背景与目的:对于大型垂体腺瘤,传统的开颅和经蝶入路手术均难以全切,本文探讨内镜经鼻蝶入路切除大型垂体腺瘤的手术技术。方法:回顾性分析2000年9月~2005年12月间治疗的大型垂体腺瘤患者39例,术前均行头CT、MRI及内分泌学检查,手术采... 背景与目的:对于大型垂体腺瘤,传统的开颅和经蝶入路手术均难以全切,本文探讨内镜经鼻蝶入路切除大型垂体腺瘤的手术技术。方法:回顾性分析2000年9月~2005年12月间治疗的大型垂体腺瘤患者39例,术前均行头CT、MRI及内分泌学检查,手术采用内镜经鼻蝶入路肿瘤切除术。结果:本组患者无手术死亡,肿瘤全切除23例(60.0%),近全切除14例(35.9%),部分切除2例(5.1%)。术后随访6~24个月,症状和内分泌学指标均有所改善,肿瘤复发2例。结论:内镜经鼻蝶手术是治疗大型垂体腺瘤微创、安全的方法。 展开更多
关键词 垂体腺瘤 内镜 经鼻蝶手术
下载PDF
经额下-第三脑室联合入路切除巨大垂体腺瘤与颅咽管瘤24例报告 被引量:1
17
作者 楚功仁 张佳栋 +2 位作者 胡明伟 陈航 史锡文 《中国临床神经外科杂志》 2002年第4期205-206,共2页
目的 介绍经额下-第三脑室联合入路切除巨大垂体腺瘤及颅咽管瘤的途径、体会及疗效。方法 额部开颅,先经侧脑室-室间孔达第三脑室,切除第三脑室肿瘤,此时因侧脑室及第三脑室已经开放,颅内压明显降低,可以很容易地抬起额叶,显露并切除鞍... 目的 介绍经额下-第三脑室联合入路切除巨大垂体腺瘤及颅咽管瘤的途径、体会及疗效。方法 额部开颅,先经侧脑室-室间孔达第三脑室,切除第三脑室肿瘤,此时因侧脑室及第三脑室已经开放,颅内压明显降低,可以很容易地抬起额叶,显露并切除鞍上及鞍内肿瘤。结果 4例全切除,20例次全切除,无死亡病例。24例术前均有不同程度视觉障碍,其中10例在住院期间视力视野已有改善,8例术后出现尿崩,经治疗1~2周好转。结论 当垂体瘤或颅咽管瘤长入第三脑室时,经额下-第三脑室入路是较理想的手术入路。 展开更多
关键词 垂体腺瘤 颅咽管瘤 手术入路 经额下-第三脑室联合入路
下载PDF
Degrees of Diaphragma Sellae Descent during Transsphenoidal Pituitary Adenoma Resection:Predictive Factors and Effect on Outcome 被引量:3
18
作者 Ahmed Abdelmaksoud Peng FU +5 位作者 Osamah Alwalid Ahmed Elazab Ahmed Zalloom Wei XIANG Xiao-bing JIANG Hong-yang ZHAO 《Current Medical Science》 SCIE CAS 2018年第5期888-893,共6页
This study is aimed to classify degrees of diaphragma sellae (DS) descent into sella turcica according to the surgical field block caused by the descent and to construct predictive imaging criteria for the degree of d... This study is aimed to classify degrees of diaphragma sellae (DS) descent into sella turcica according to the surgical field block caused by the descent and to construct predictive imaging criteria for the degree of descent,and in addition,to determine whether there is any correlation between the degree of DS descent and the operative outcome (in the form of cerebrospinal fluid leak and/or presence of residual tumor).Totally,72 patients were enrolled in our study.Their clinical and radiological data as well as the high definition videos of operations were retrospectively reviewed.The degree of DS descent during the operation was classified into five degrees according to surgical field block caused by the descent.We investigated the correlation between these five degrees and the clinical findings,radiological findings as well as the surgical outcomes.We found that the most important determining factors of DS descent degree were the volume and the height of the tumor portion above diaphragma opening.On the other hand,the total tumor volume,the maximum tumor height and the morphological pattern according to Wilson's system (modified from Hardy) had no statistically significant correlation with DS degree of descent.Presence of residual tumor on postoperative magnetic resonance images was significantly correlated with Wilson's classification and with supradiaphragmatic tumor height.On the other hand,cerebrospinal fluid leak showed no statistically significant difference between variable degrees of DS descent.Volumetric data of the tumor portion above the diaphragma opening are more important than morphological data for prediction of surgical field block caused by descended DS.While DS prolapse significantly increases the difficulty of the operative procedure,residual tumor presence is mainly dependent on morphological classification,especially cavernous sinus invasion. 展开更多
关键词 diaphragma sellae PITUITARY macroadenoma TRANSSPHENOIDAL surgery CEREBROSPINAL fluid LEAK
下载PDF
垂体大腺瘤的神经导航经蝶手术治疗 被引量:1
19
作者 赵元立 于书卿 +1 位作者 王嵘 赵继宗 《中华神经外科疾病研究杂志》 CAS 2005年第5期406-410,共5页
目的探讨在向鞍上和鞍旁生长的垂体大腺瘤的经蝶手术中,应用神经导航系统辅助,提高手术治疗效果的临床经验。方法自1997年至2003年,在经蝶手术中应用导航系统治疗向鞍上和鞍旁生长的垂体大腺瘤63例(男性41例,女性22例,平均年龄58.3岁)... 目的探讨在向鞍上和鞍旁生长的垂体大腺瘤的经蝶手术中,应用神经导航系统辅助,提高手术治疗效果的临床经验。方法自1997年至2003年,在经蝶手术中应用导航系统治疗向鞍上和鞍旁生长的垂体大腺瘤63例(男性41例,女性22例,平均年龄58.3岁)。在传统的经蝶入路基础上,术前行CT或MRI扫描定位以及数据的三维重建,术中在导航系统辅助下,完成鞍区及邻近结构的实时动态解剖定位。同时还对导航系统的精确性进行评估。结果肿瘤全切26例,近全切除36例,部分切除1例。术后出现脑脊液鼻漏、内分泌功能障碍等并发症15例,占23.8%,死亡1例,死亡率1.6%。导航系统定位具有足够的精确性,平均误差(2.3±1.1)mm。结论导航系统应用于垂体大腺瘤经蝶手术,有助于术中精确、动态地鉴别蝶窦和鞍区解剖结构,准确判断肿瘤切除情况,保护正常神经血管,避免了传统手术模式术中使用X射线的副作用,对于提高手术效果有一定帮助。 展开更多
关键词 垂体大腺瘤 导航 经蝶入路
下载PDF
经鼻腔-蝶窦入路神经内镜切除垂体大腺瘤58例临床分析 被引量:1
20
作者 洪文明 程宏伟 王斌 《生物医学工程与临床》 CAS 2020年第2期136-140,共5页
目的分析经鼻腔-蝶窦入路神经内镜下手术治疗垂体大腺瘤的疗效。方法回顾性分析采用经神经内镜下手术治疗垂体大腺瘤患者58例,其中男性22例,女性36例;年龄32~69岁,平均年龄45.3岁。所有患者均使用神经内镜经鼻腔-蝶窦入路切除肿瘤。术... 目的分析经鼻腔-蝶窦入路神经内镜下手术治疗垂体大腺瘤的疗效。方法回顾性分析采用经神经内镜下手术治疗垂体大腺瘤患者58例,其中男性22例,女性36例;年龄32~69岁,平均年龄45.3岁。所有患者均使用神经内镜经鼻腔-蝶窦入路切除肿瘤。术后进行随访评估,包括神经影像、内分泌及视力检查。统计分析内镜治疗垂体腺瘤的视力改善率及内分泌治愈率,观察分析其肿瘤切除情况、手术并发症情况。结果随访时间1~32个月,平均随访15.3个月。58例患者中,内镜手术全切48例(82.8%),次全切8例(13.8%),部分切除2例(3.4%)。术后患者视力改善率91.2%(31/34),内分泌治愈率35.7%(10/28)。术后短暂脑脊液鼻漏4例,无永久性脑脊液鼻漏。短暂性尿崩症10例,无永久性尿崩症。无死亡或者植物生存等严重并发症。结论经鼻腔-蝶窦入路神经内镜下切除垂体大腺瘤是一种安全、可靠、有效的治疗方式。 展开更多
关键词 垂体腺瘤 神经内镜 经鼻腔-蝶窦入路 手术治疗
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部